1 / 7

Cost of cardiovascular diseases in the United Kingdom

Cost of cardiovascular diseases in the United Kingdom. Claudia Soiland-Reyes Journal Club 28 th November 2012. Paper: Heart 2006, Cost of cardiovascular diseases in the United Kingdom. Luengo-Fernández , R., Leal, J., Gray , A., Pettersen , S. and Rayner , M.

honorato-andrews
Télécharger la présentation

Cost of cardiovascular diseases in the United Kingdom

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cost of cardiovascular diseases in the United Kingdom Claudia Soiland-Reyes Journal Club 28th November 2012

  2. Paper: Heart 2006, Cost of cardiovascular diseases in the United Kingdom. Luengo-Fernández, R., Leal, J., Gray, A., Pettersen, S. and Rayner, M. • Objective: “To estimate the economic burden of cardiovascular disease (CVD) in the United Kingdom, including health and non-healthcare costs, and the proportion of total CVD cost due to coronary heart disease (CHD) and cerebrovascular disease.”

  3. Study characteristics • Cost-of-illness • Prevalence-based approach (All UK residents in 2004 with CVD and subgroups) • Societal perspective • Top-down approach to calculate total expenditure based on aggregate data on morbidity, mortality, resource use and disease-related costs.

  4. Healthcare expenditure • Healthcare expenditure • Community health and social services (England figures adjusted to UK) • Primary care (CVD consultation rates from national survey) • Accident and Emergency care (HES) • Hospital day cases (HES) • Inpatient care (product of average length of stay, no. CVD discharges) • Cardiac rehabilitation services (proportion of CVD hospitalisations) • Outpatient care (CVD attendances) • Drugs ( CHD and cerebrovascular proportions estimated using France, Germany and Netherlands proportions)

  5. Non-healthcare costs • Informal care – Opportunity cost of unpaid care. • Informal care time of carers in retirement or not in employment was valued on the basis of minimum wages – but it’s not clear how do they estimate this proportion. • Only considering costs in current year but not future losses as in productivity losses • Productive losses arising from morbidity and premature death • Total morbidity loss calculated based on the “friction period” estimated to be 90 days, but mortality costs calculated across all the premature years.

  6. Total cost of CVD: £29.1 billion • CHD: 29% - £8.5 billion • Cerebrovascular disease: 27% - £8 billion • Other CVD diseases: 44% • Healthcare costs: 60% • Productivity losses: 23% • Informal care-related costs: 17%

  7. Points for discussion • Extrapolation of figures • UK estimations extrapolated based on population ratios! However CHD prevalence rates are higher in Scotland • Different national guidelines that imply different healthcare costs • Cost to society • Friction period for productivity losses due to morbidity but not for mortality • Informal care costs calculated based on wages and not salaries. • Don’t know of a more recent national estimate • Reference costs were not published back then, figures could be updated

More Related